Key result
Increased pulmonary blood flow combined with monocrotaline induced specific pulmonary neointimal lesions and the expression of transcription factors ATF3 and EGR-1 in a rat model of PAH.
Identification of ATF3, EGR-1, and iloprost-responsive pathways in a rat model of flow-associated PAH provides potential new therapeutic targets for pulmonary vascular remodeling.
Answers are grounded in this paper and cite their sources.
ATF3 and EGR-1 merit investigation as targets in flow-associated PAH remodeling; leaves open translation from this rat model.
Pulmonary arterial hypertension (PAH) is a pulmonary angioproliferative disease with high morbidity and mortality, characterized by a typical pattern of pulmonary vascular remodeling including neointimal lesions. In congenital heart disease, increased pulmonary blood flow has appeared to be a key mediator in the development of these characteristic lesions, but the molecular mechanisms underlying the pulmonary vascular lesions are largely unknown. We employed a rat model of flow-associated PAH, which induced specific pulmonary neointimal lesions. We identified gene expression profiles in rats specifically related to the addition of increased pulmonary blood flow to monocrotaline and the associated occurrence of neointimal lesions. Increased pulmonary blood flow induced the expression of the transcription factors activating transcription factor-3 (ATF3) and early growth response factor-1 (EGR-1), for which presence was confirmed in neointimal lesions. Monocrotaline alone induced increased numbers of activated mast cells and their products. We further identified molecular pathways that may be involved in treatment with the prostacyclin analog iloprost, a vasoactive compound with clinically beneficial effects in patients with PAH, which were similar to pathways described in samples from patient studies. These pathways, associated with the development of angioproliferative lesions as well as with the response to therapy in PAH, may provide new therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Albada et al. (2009) studied Pulmonary arterial hypertension. Increased pulmonary blood flow and monocrotaline vs. Monocrotaline alone was evaluated on Gene expression profiles associated with neointimal lesions. Increased pulmonary blood flow combined with monocrotaline induced specific pulmonary neointimal lesions and the expression of transcription factors ATF3 and EGR-1 in a rat model of PAH.
Synapse has enriched 10 related papers. Consider them for comparative context: